Showing 1 - 20 results of 4,285 for search '(( design ((tools decrease) OR (fold decrease)) ) OR ( a ((large decrease) OR (marked decrease)) ))', query time: 0.64s Refine Results
  1. 1
  2. 2

    Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

    Published 2024
    “…Among them, W<sub>3</sub>BipY<sub>8</sub>-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W<sub>3</sub>BipY<sub>8</sub> but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W<sub>3</sub>BipY<sub>8</sub>. …”
  3. 3
  4. 4
  5. 5
  6. 6

    Survey tool development process. by Lisa Thiele (6468056)

    Published 2025
    “…The study specific survey tool was developed through a multistage process with healthcare consumer input during creation and testing.…”
  7. 7

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  8. 8

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  9. 9

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  10. 10

    PCA-CGAN K-fold experiment table. by Chao Tang (10925)

    Published 2025
    “…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. …”
  11. 11

    PCAECG-GAN K-fold experiment table. by Chao Tang (10925)

    Published 2025
    “…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20